Nexvet Biopharma Ord (NVET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Sales | 0 | 25 | 13 | 329 |
| Gross Profit | N/A | 25 | 13 | 329 |
| Operating Expenses | 22,170 | 20,036 | 10,043 | 4,825 |
| Operating Income | -22,170 | -20,011 | -10,030 | -4,496 |
| Other Income | 2,805 | 8,154 | 3,320 | 1,255 |
| Pre-tax Income | -19,365 | -11,857 | -6,710 | -3,241 |
| Net Income Continuous | -19,365 | -11,857 | -6,710 | -3,241 |
| Net Income | $-19,365 | $-11,857 | $-6,710 | $-3,241 |
| EPS Basic Total Ops | -1.68 | -2.27 | -6.70 | -3.62 |
| EPS Basic Continuous Ops | -1.68 | -2.27 | -6.70 | -3.62 |
| EPS Diluted Total Ops | -1.68 | -2.27 | -6.70 | -3.62 |
| EPS Diluted Continuous Ops | -1.68 | -2.27 | -6.70 | -3.62 |
| EPS Diluted Before Non-Recurring Items | -1.68 | -2.27 | -2.07 | N/A |
| EBITDA(a) | $-21,654 | $-19,857 | $-9,974 | $-4,485 |